|
|
|
|
There are several technologies available for microencapsulating drugs. Finding a contract development and manufacturing organization (CDMO) that possesses the experience and expertise necessary to optimize a drug’s efficacy and manufacturing during formulation is integral to a product’s ultimate clinical and commercial success.
|
|
|
|
|
Dysphagia significantly reduces treatment compliance, particularly in elderly patients. While compounded formulations are common, they can compromise product quality. Uncover how microencapsulation enabled a water-soluble powder that improves patient adherence.
|
|
|
|
|
A European pharmaceutical company sought to improve pancreatic enzyme delivery for patients with swallowing difficulties, especially children. Learn how MMTS™ enabled sprinkle-on dosing, broad dose flexibility, G-tube compatibility, and improved adherence across ages.
|
|
|
|
|
Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.
|
|
|
|
|
A drug sponsor developed a taste-masked, convenient formulation of a very bitter API for HIV patients ages two and older. Discover how a powder dosage form overcame challenges with at-home administration, storage conditions, and flexible dosing requirements.
|
|
|
